Q2-2026: Beat consensus by 44.1%, EPS $3.09 vs $2.1437 estimateMEDIUMLONGJul 29
Point72 Asset Management, L.P. cut 61% of INCY (2026Q1)HIGHSHORTJul 24
Point72 Asset Management, L.P. added +2036% to INCY (2026Q1)HIGHLONGJul 24
MILLENNIUM MANAGEMENT LLC added +339% to INCY (2026Q1)HIGHLONGJul 24
TWO SIGMA INVESTMENTS, LP added +1032% to INCY (2026Q1)HIGHLONGJul 24
Bridgewater Associates, LP cut 60% of INCY (2026Q1)HIGHSHORTJul 24
Phase 3 trial terminated early - INCYTE Nivolumab and Epacadostat With Plat...HIGHSHORTJun 23
Phase 3 trial terminated early - INCYTE A Study of Baricitinib (LY3009104)...HIGHSHORTJun 22